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The absence of tumor necrosis factor (TNF) causes lethal infection by Leishmania major 
in normally resistant C57BL/6J (B6.WT) mice. The underlying pathogenic mechanism of 
this fatal disease has so far remained elusive. We found that B6.WT mice deficient for the 
tnf gene (B6.TNF−/−) displayed not only a non-healing cutaneous lesion but also a serious 
infection of the liver upon L. major inoculation. Infected B6.TNF−/− mice developed an 
enlarged liver that showed increased inflammation. Furthermore, we detected an accu-
mulating monocyte-derived macrophage population (CD45+F4/80+CD11bhiLy6Clow) that 
displayed a M2 macrophage phenotype with high expression of CD206, arginase-1, and 
IL-6, supporting the notion that IL-6 could be involved in M2 differentiation. In in vitro 
experiments, we demonstrated that IL-6 upregulated M-CSF receptor expression 
and skewed monocyte differentiation from dendritic cells to macrophages. This was 
countered by the addition of TNF. Furthermore, TNF interfered with the activation of IL-6-
induced gp130-signal transducer and activator of transcription (STAT) 3 and IL-4-STAT6 
signaling, thereby abrogating IL-6-facilitated M2 macrophage polarization. Therefore, 
our results support the notion of a general role of TNF in the inflammatory activation 
of macrophages and define a new role of IL-6 signaling in macrophage polarization 
downstream of TNF.
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inTrODUcTiOn
The infectious disease leishmaniasis has been identified as a “neglected tropical disease” by the 
WHO and affects a significant number of people worldwide. The infection is caused by members 
of the intracellular protozoan parasite genus Leishmania spp. (1) and occurs when parasites are 
transmitted to their human hosts by Phlebotomus spp. or Lutzomyia spp. sandfly vectors during 
their blood-meal (2). Depending on the specific parasite species and the immune response of the 
host, infection with Leishmania spp. results in a variety of clinical manifestations that can range 
from self-healing skin lesions to progressive and ultimately fatal infections of visceral organ such as 
the spleen and liver (3). In the mammalian host, the parasites reside in their amastigote form within 
macrophages and dendritic cells (DCs) (4). The experimental model of cutaneous leishmaniasis, 
which is based on a subcutaneous inoculation with isolates of the species Leishmania major features 
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a strong genetic dichotomy. Mice of a C57BL/6 background 
(B6.WT) display a localized, self-healing infection characterized 
by interferon-γ (IFN-γ) production, while mice of the BALB/c 
background respond to infection with a preferential production 
of Th2 cytokines, such as IL-4, IL-10, and IL-13. These mice suc-
cumb to the infection after a progressive course of disease and a 
marked visceralization of the pathogen. This genetic dichotomy 
as a basis of resistance or susceptibility was instrumental in the 
development of the T helper (Th)1/Th2 paradigm (1).
The early expression of these respective cytokines has a pro-
found effect on the activation state of macrophages, the predomi-
nant host cells of these pathogens. The T cell and NK cell cytokine 
IFN-γ triggers a classical activation that equips macrophages 
located in skin and local draining lymph node with mechanisms 
such as an upregulation of inducible nitric oxide synthase (iNOS) 
that allow an effective response to the challenge (5). In contrast, the 
cytokines IL-4, IL-10, and IL-13 result in an alternative activation 
in macrophages (6) that allows them to contribute to tissue remod-
eling and wound healing (7). While these cytokines have clearly 
accepted general roles in the establishment of an immune response 
to pathogens the proinflammatory cytokine tumor necrosis fac-
tor (TNF) has been seen as a cofactor that had an important but 
limited role in the immune defense (8). Nevertheless, infection 
experiments using L. major, specifically the BNI substrain, and 
other intracellular pathogens demonstrated a strong protective 
effect of TNF since L. major BNI infected TNF-deficient mice 
succumbed rapidly to the parasites despite a strong Th1-type 
response (9, 10). Recent observations have allowed an insight in 
the underlying deficiencies that cause this susceptibility. It could 
be demonstrated that in the L. major model TNF is necessary to 
prevent an ill-timed accumulation of alternatively activated mac-
rophages concurrently to classically activated macrophages thus 
indicating a new and unique role for TNF (11). In the absence 
of TNF an elevated accessibility of arginase-1 (Arg-1) promoter 
and enhancer structures permitted a hyper-expression of Arg-1 
and caused a subsequent lack of nitric oxide (NO) production 
presumably due to competition between the two enzymes iNOS 
and Arg-1, that depleted their common substrate l-arginine (12).
This mechanistic model of TNF-dependent restriction of 
alternative activation and the consequences for a host that lacks 
TNF has been established in skin and draining lymph nodes of 
L. major BNI infected mice (12). Other organs such as spleen 
and liver also show significant reproduction of parasites which 
is not detectable in TNF-positive hosts. The immune response 
in these organs has not yet been investigated in more detail and 
we hypothesized that we would also find increased alternative 
activation of macrophages. By analyzing L. major BNI infection 
in the liver, we found a comparatively low iNOS expression in 
B6.TNF−/− macrophages and an accumulation of a myeloid popu-
lation that exhibited an alternatively activated-like macrophage 
phenotype, with high expression of Arg-1, CD206 and IL-6. In an 
in vitro assay, we demonstrated that bone marrow-derived DCs 
treated with IL-6 increased the expression of M-CSFR and gen-
erated less CD11c+ cells, while adding TNF reinstated CD11c+ 
cell generation and concurrently inhibited M-CSFR expression. 
Furthermore, we could show that both TNF and IL-6 had a regu-
latory effect on M2 macrophage differentiation which depends 
on modulation of mIL-6/gp130/signal transducer and activator 
of transcription (STAT) 3 or IL-4-STAT6. These findings of our 
study are emphasizing again that expression of TNF is critical to 
preventing a spread of parasites to visceral organs.
resUlTs
Progressive liver infection by L. major  
Bni in B6.TnF−/− Mice
Infection of C57BL/6 mice that lack an expression of TNF with 
L. major BNI results in a progressive course of disease and vis-
ceralization while B6.WT mice contain the infection and recover 
spontaneously (10). In our infection experiments, a significant 
lesion was observed in both B6.WT and B6.TNF−/− mice from day 
21 after infection. While the footpads swelling remained moder-
ate in B6.WT mice and subsided after day 35, B6.TNF−/− mice 
showed a progressively increasing footpad swelling (Figure 1A). 
Additionally, in B6.TNF−/− mice the infection spread to visc-
eral organs such as the liver resulting in a mild hepatomegaly 
(Figure 1B) and a significant increase in liver weight (Figure 1C). 
Parasites in the liver were detected from day 21 after infection 
increasing in number to more than 3 × 105 parasites per gram 
liver tissue at day 42 postinfection (p.i.), while the liver of infected 
B6.WT mice remained essentially parasite free (Figure 1D).
Discrete inflammatory Foci in the liver  
of B6.TnF−/− Mice during cutaneous 
leishmaniasis
In both B6.WT and B6.TNF−/− mice normal, uninfected liver 
tissue consists of hexagonal hepatocytes radiating from the 
region of the central vein toward the periphery. From day 35 after 
infection, a point in time coinciding with a significant increase 
of liver weight and parasitic burden (Figures  1B,C), abnormal 
liver structures such as swelling of hepatocytes and diffusely 
infiltrating inflammatory cells could be detected in L. major BNI-
infected B6.TNF−/− mice (Figure  2A). Additionally, inflamma-
tory foci appeared almost exclusively in infected gene-deficient 
mice (Figure  2A). The generic macrophage marker CD68 was 
used to determine the phenotype of the cell focus (Figure 2B). 
Weak hepatic expression of CD68 was observed in B6.WT and 
B6.TNF−/− control groups, which was upregulated at day 42 after 
infection compared to its B6.WT counterpart. Cells that were 
CD68+ were mainly detected in areas around the borders of 
inflammatory foci. Taken together, these results suggested that 
infiltration of inflammatory cells and hepatic inflammation were 
significantly elevated in B6.TNF−/− mice, compared to the cor-
responding B6.WT mice. Interestingly, the number of inflamma-
tory foci was significantly higher in B6.TNF−/− mice as compared 
to that in B6.WT mice (Figure 2C).
cytokines levels in serum of B6.WT  
and B6.TnF−/− Mice after infection
Cytokine levels in the serum are an indication of the type of 
immune response to L. major BNI (9). The titers of monocyte 
chemoattractant protein (MCP)-1, IL-6, IFN-γ, IL-10, TNF, and 
FigUre 1 | Liver enlargement and increased parasite burden in B6.TNF−/− mice. While the lesion and liver size and weight remained initially identical between B6.
WT and B6.TNF−/− genotypes it increases significantly in footpads (a) and liver (B,c) of B6.TNF−/− mice 42 days after L. major BNI infection. Six B6.WT and B6.
TNF−/− mice were used to determine lesion size (a), and five mice were used to determine liver weight at each time point (c). Error bars represent the mean ± SD 
from one representative of three independent experiments. The p-values were calculated using a two tailed Mann–Whitney U-test (*p < 0.05, **p < 0.01). (c) The 
number of viable parasites in the liver tissue of B6.WT and B6.TNF−/− mice was determined by limiting dilution analysis (D). The mean parasitic burden in the liver 
tissue of five mice from one representative experiment is shown. One circle represents one animal (black: B6.WT; white: B6.TNF−/−). The results were confirmed by 
the other two independent replications. All data are represented as mean ± SD. Significance was calculated using a two tailed Mann–Whitney U-test (*p < 0.05, 
**p < 0.01).
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IL-12 (p70) were determined in the serum of L. major BNI-
infected B6.WT and B6.TNF−/− mice using a cytokine bead array 
(CBA) and compared to uninfected controls.
Serum levels of the proinflammatory cytokines MCP-1, IL-6, 
and IFN-γ increased significantly in B6.TNF−/− mice over the 
course of disease (Figure 3). High levels of MCP-1 were detected 
in the B6.TNF−/− mice after day 28 after infection (Figure 3A) 
indicating that L. major BNI-induced inflammation increased the 
potential to recruit monocytes. IL-6 was found to be increased by 
17 times at the same point in the course of infection and 9 times 
at day 35 and day 42 after infection when compared to infected 
B6.WT mice (Figure 3B). Finally, a high concentration of IFN-γ 
is characteristic for a Th1-type immune response in both geno-
types and was determined to validate our data. Similar to previ-
ously published results (9), B6.TNF−/− mice showed a significant 
increase of IFN-γ (Figure 3C) compared to that in B6.WT (day 
28 after infection: mean ± SD, 269.45 ± 163.56 versus mean ± SD, 
3.50 ± 1.49; day 35 after infection: mean ± SD, 668.39 ± 424.14 
versus mean ± SD, 3.50 ± 2.46; day 42 after infection: mean ± SD, 
766.03 ± 622.3 versus mean ± SD, 6.14 ± 4.11). Serum concentra-
tion of IL-10 (limit of detection 17.5 pg/ml) and IL-12p70 (limit 
of detection 10.7 pg/ml) remained below the detection limit for 
the assay in more than half of the serum samples throughout the 
course of infection (data not shown). TNF was only observed in 
B6.WT mice (data not shown).
a Monocyte-Derived Macrophage (Mo-M) 
Population accumulates in the liver of  
L. major Bni-infected B6.TnF−/− Mice
A strong accumulation of inflammatory myeloid cells has been 
described in skin and draining lymph node in L. major BNI 
infection (11). Furthermore, it has been demonstrated that TNF 
is necessary for classically activated macrophage phenotype (12). 
Therefore, we analyzed the quantity and composition of infiltrat-
ing inflammatory cells in the liver of B6.WT and B6.TNF−/− mice 
using comprehensive flow cytometric analysis with two different 
panels over the course of infection.
Three distinct subsets were characterized based on the 
expression of CD11b, Ly6C, CD45, and F4/80 as described 
previously (13). The liver-resident Kupffer cells (KCs) were 
defined as CD45+F4/80+CD11b−Ly6C− population. Recruited 
FigUre 3 | Cytokine secretion as measured by cytokine bead array using 
flow cytometry. Serum levels of (a) monocyte chemoattractant protein-1 
(MCP-1), (B) IL-6, and (c) interferon-γ (IFN-γ) were measured over the course 
of Leishmania major infection between B6.WT and B6.TNF−/− mice. The red 
dashed lines represent the limit of detection for each cytokine (IL-6 5 pg/ml, 
MCP-1 52.7 pg/ml, and IFN-γ 2.5 pg/ml). Concentrations were expressed 
and compared with the basal level found in B6.WT and B6.TNF−/− mice 
without infection. Each value represents the mean of three independent 
experiments and each experiment was performed in five mice. Error bars 
denote SD. The p-values were calculated using two tailed Mann–Whitney 
U-test (**p < 0.01, ***p < 0.001).
FigUre 2 | Liver morphology of B6.WT and B6.TNF−/− mice. (a) 
Representative H&E-stained liver sections of 15 B6.WT and B6.TNF−/− mice 
are shown before infection and at day 42 after infection. B6.TNF−/− mice 
show an increased infiltration of inflammatory cells and the presence of 
inflammatory foci (arrowhead; magnification 400×). (B) Liver tissue from 
B6.WT and B6.TNF−/− mice (uninfected and 42 days after infection). At day 
42 after infection, CD68 immunostaining is markedly increased in B6.
TNF−/− mice compared to the B6.WT group. Bar = 25 μm for all the pictures. 
(c) The number of inflammatory foci per area is shown. The p-values were 
calculated using two tailed Mann–Whitney U-test (***p < 0.001).
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inflammatory monocytes (Mo) which differentiate to Mo-M 
and potentially to inflammatory DCs (Mo-DC) were defined 
as CD45+F4/80+CD11blowLy6Chi. Finally, Mo-M displayed the 
phenotype of CD45+F4/80+CD11bhiLy6Clow (13–15) (#or gating 
strategy and flow cytometric identification of subpopulations see 
Figure S1 in Supplementary Material).
The number of KCs was not significantly different between 
the genotypes over the course of a L. major BNI infection 
except for day 21 after infection. At this point in time, the 
CD45+F4/80hiCD11b−Ly6C− population was around two-
fold higher  in B6.WT mice as compared to B6.TNF−/− mice 
(Figures  4A,B). The number of inflammatory monocytes 
increased in correlation with the footpad swelling irrespec-
tive of the genotype. At day 42, the infiltrating monocytes 
started to decrease (B6.WT) or reached a plateau (B6.TNF−/−) 
(Figures 4A,C). At the same time, Mo-M which represented a 
small population in B6.WT mice were elevated significantly in 
B6.TNF−/− mice (Figures  4A,D). To analyze the specific role 
of TNF in the accumulation of Mo-M, we employed TNF-
competent mice of the BALB/c strain which are highly susceptible 
to L. major BNI infection and display progressive visceralization 
(Figures S2A,B in Supplementary Material). This control experi-
ment showed a Mo-M population comparable to B6.WT mice 
and indicated that the accumulation of the Mo-M population 
depends on TNF.
Infection leads to a strong increase of CD11c+iNOS+TNF+ 
inflammatory DCs (here termed Mo-DC) at the infection site. 
These cells are also derived from inflammatory monocytes 
and act as effector and antigen-presenting cells. Therefore, we 
investigated whether the absence of TNF affects the differen-
tiation process of Mo-DCs during L. major-BNI induced liver 
infection and we examined the expression of CD11c based on 
CD45+CD11bhiLy6Chi population. Mice of both genotypes had a 
very distinct CD11c+ CD11bhi Ly6Chi population of comparable 
size. In B6.TNF−/− mice the populations displayed a comparatively 
FigUre 4 | Analysis of resident and inflammatory myeloid populations in the liver in Leishmania major infected B6.WT and B6.TNF−/− mice. (a) Flow cytometry 
analysis was used to demonstrate the presence of three different liver macrophage populations based on the markers CD45, F4/80, CD11b, and Ly6C from B6.WT 
and B6.TNF−/− mice and to analyze the changes of these populations over the course of L. major BNI infection. Kupffer cells (KCs) were defined as 
CD45+F4/80+CD11b−Ly6C−, inflammatory monocytes (Mo) as CD45+F4/80+CD11blowLy6Chi and monocyte-derived macrophages (Mo-M) as 
CD45+F4/80+CD11bhiLy6Clow. A representative staining is shown. Quantification by flow cytometry of the total populations of (B) KC, (c) Mo, and (D) Mo-M from five 
B6.WT and B6.TNF−/− mice in the course of L. major BNI infection is shown. Each error bar represents means ± SD from one experiment. Results were confirmed 
by two independent experiments. The p-values were calculated using two tailed Mann–Whitney U-test (**p < 0.01).
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lower expression of CD11b, Ly6C, and CD11c than B6.WT mice 
(Figures S3A,B in Supplementary Material), which could indicate 
differences of inflammatory status or maturity of Mo-DCs.
The Mo-M Population in TnF−/− Mice 
Display an alternatively activated 
Phenotype with high il-6 expression
As shown above, B6.TNF−/− mice fail to clear the parasites 
from the liver and display an accumulation of a TNF-specific, 
unique Mo-M accumulation. To further investigate this Mo-M 
population in B6.TNF−/− mice during murine leishmaniasis, we 
followed the previously used gating strategy and combined both 
CD11b+Ly6C+ populations since CD11bhighLy6Clow are missing 
in B6.WT mice (Figure 5A). We characterized the phenotypes 
using intracellular flow cytometry of the markers IL-6, CD206 
and, as control for the quality of the sort, IFN-γ. The intracellular 
antigens were depicted against SSC (Figure 5B). Corresponding 
to the increased IL-6 secretion in serum of infected B6.TNF−/− 
mice, an increased level of IL-6 expression was detected in liver 
macrophages. Although IL-6 is regarded as proinflammatory 
cytokine, it could be involved in the establishment of a Th2 
FigUre 5 | Phenotypic characterization of monocyte-derived macrophages in the liver of B6.TNF−/− mice. (a) Gating strategy used in these experiments. (B) The 
expression of IL-6, CD206, and interferon-γ were investigated in the combined population from B6.WT and B6.TNF−/− mice at day 42 p.i. using flow cytometry. (c) 
Gene expression of IL-6, CD206, inducible nitric oxide synthase, and arginase-1 relative to β-actin expression in the combined population of B6.WT and B6.TNF−/− 
mice at d42 p.i. Each error bar represents the means ± SD from five mice in one experiment, and results were confirmed by further two independent experiments. 
The p-values were calculated using a two tailed Mann–Whitney U-test (*p < 0.05, **p < 0.01).
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response which in turn, could modulate the activation pathway 
of the macrophage differentiation. Additionally, the macrophage 
mannose receptor CD206, was strongly upregulated. As expected, 
there was no difference in the presence of IFN-γ between B6.WT 
and B6.TNF−/− because IFN-γ is not produced by Mo or Mo-M. 
In summary, we found SSC, IL-6 and CD206 increased in the 
combined Mo and Mo-M of B6.TNF−/−mice, indicating that 
this population comprises are large proportion of alternatively 
activated macrophages in B6.TNF−/− mice during L. major BNI 
infection. The detection of SSChigh cells in B6.TNF−/− mice was 
striking and indicates a marked presence of cells with high granu-
larity that could represent infected cells.
Previously, it had been shown that a CD11bhi Ly6Clow myeloid 
population harbored a markedly increased number of parasites 
in skin and draining lymph nodes (11). Because infected cells 
with a large burden of parasites are fragile and difficult to detect 
using flow cytometry, we sorted the distinct Mo and Mo-M 
populations from B6.WT and B6.TNF−/− mice and conducted a 
Romanowsky stain (Diff-Quik). There was no distinctive visible 
difference between Mo and Mo-M cells. In B6.WT mice there 
were no visible parasite associated with macrophages. In con-
trast, in both CD11b+Ly6Chi and CD11b+Ly6Clow macrophage 
populations isolated from B6.TNF−/− mice parasites could be 
detected inside and on the surface of macrophages (Figure S4 in 
Supplementary Material).
To further analyze the Mo-M population in the liver during 
L. major BNI infection, we isolated these cells and characterized 
their phenotype with regard to the gene expression of these 
marker molecules using qPCR. We confirmed our flow cytom-
etry results and showed that IL-6 and the alternative activation 
FigUre 6 | Inducible nitric oxide synthase (iNOS) and CD206 expression in B6.TNF−/− mice. Immunofluorescence staining of (a) CD11b, iNOS, and Leishmania 
major and (B) CD11b, CD206, and L. major in liver tissue of B6.WT (upper panel) and B6.TNF−/− mice (lower panel) 42 days after infection. Single color staining is 
shown for L. major (green), CD206 and iNOS (red), CD11b (gray), and DAPI (blue). The single colors have been merged. The figure represents one of three 
independent experiments.
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markers including Arg-1 and CD206 were significantly higher 
expressed in B6.TNF−/− mice as compared to B6.WT mice. 
In contrast to previous results, in the liver iNOS expression was 
decreased significantly in B6.TNF−/− mice (Figure 5C).
Macrophage activation is correlated  
with Parasitic Burden in liver
The regulation of myeloid iNOS expression after challenge in vivo 
is complex and influenced by factors such as pathogen, genetic 
background and cytokine environment. Therefore, we examined 
the response of CD11b+ cells to L. major BNI in the livers of 
B6.WT and B6.TNF−/− mice (Figures  6A,B). Mice from both 
genotypes showed a strong presence of CD11b+ cells at day 42 
after infection while L. major amastigotes could only be detected 
directly in B6.TNF−/− mice (Figures  6A,B). The absence of 
L. major in the livers of B6.WT mice was correlated with a strong 
iNOS expression, while in the absence of TNF, iNOS expression 
was decreased (Figure 6A) similar to the situation in susceptible 
BALB/c mice (Figure S2A in Supplementary Material) while 
CD206 expression was increased and associated with a strong 
presence of L. major (Figure 6B). Thus, these results suggested 
a presence of alternatively activated macrophages during leish-
manial infection in the liver in B6.TNF−/− mice.
TnF and il-6 Modulate the Process of 
Monocyte Differentiation to Macrophage 
or Dc In Vitro
One of the cytokines which was upregulated significantly in the 
liver is IL-6 (compare Figure 3). The presence of IL-6 has been 
shown to modulate the differentiation of monocytes and skew the 
developmental outcome to macrophages rather than DC, which 
can be reversed by TNF (16). The observed overexpression of 
IL-6 in B6.TNF−/− mice could facilitate the increased presence 
of alternatively activated macrophages in the liver. To test this 
hypothesis, we decided to use mouse bone marrow-derived 
macrophages to analyze their differentiation in the context of TNF 
and IL-6 in vitro. Bone marrow cells of B6.WT mice were cultured 
with IL-4 and granulocyte macrophage colony-stimulating factor 
(GM-CSF) resulting in 64.2% CD11b+CD11c+ DC. The addition 
of IL-6 at day 3 of culture reduced the generation of cells with this 
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phenotype to 51% (Figure 7). In contrast, culturing cells in the 
presence of a combination of IL-6 and 50 ng/ml TNF allowed the 
expression of CD11c to be restored to previous levels, indicating 
TNF reversed the differentiation process from monocytes to DCs 
which was inhibited by IL-6 (Figures 7A,B). The combination of 
GM-CSF and IL-4 potentially caused ectodomain shedding of the 
M-CSF receptor, inhibiting the differentiation of macrophages 
from monocytes (17). Thus, we next examined the level of M-CSFR 
expression when treated with IL-6 and TNF using flow cytometry, 
immunofluorescence and qPCR (Figures  7B,C). Adding IL-6 
resulted in an increased level of M-CSFR expression compared 
to the control group which was consistent with the increased 
accumulation of DCs (Figure 7A). After an additional exposure 
to TNF, IL-6-treated DCs showed a markedly reduced M-CSFR 
level (Figure  7A). Using immunofluorescence DCs showed 
increased expression of M-CSFR when treated with IL-6 alone, but 
its CD11c expression was reduced compared to the control group 
(Figure  7B). An exposure of cells to IL-6 and TNF-α together 
reduced the expression of M-CSFR and CD11c was elevated. These 
results were confirmed using qPCR (Figure 7C).
a regulatory Balance of TnF and il-6 
Mediate alternative Macrophage 
Polarization
Since TNF skewed IL-6-driven differentiation from macrophage 
to DC, we next examined whether TNF and IL-6 also affected 
alternative activation as represented by comparing F/80 and 
CD206 expression patterns. Treatment of the three different 
types of macrophages with IL-6 alone did not change M0 and M1 
phenotype, based on the expression of F4/80+CD206+ compared 
to the control group (Figure 8A). However, a significant increase 
of F4/80+CD206+ population was observed after IL-4 treatment 
(Figures  8A,B). An analysis using qRT-PCR also revealed 
increased expression of CD206 and Arg-1 mRNA, and a reduced 
iNOS mRNA expression (Figure 8C), which indicated IL-6 only 
interfered with IL-4-induced alternative activation. Furthermore, 
when applied as cotreatment with IL-6 and TNF, M0 and M1 were 
still not affected based on the parameters assessed, compared to 
IL-6-treated group. The size of the F4/80+CD206+ population 
as well as the expression of CD206 and Arg-1 mRNA were 
significantly reduced with increased concentration of TNF but 
the iNOS mRNA expression was upregulated in the presence of 
TNF-α and IL-6 (Figure 8C).
effect of a Blockade of the interaction  
of TnF and il-6
To further dissect the regulatory effect between TNF-α and IL-6 
in M2 macrophage activation, we used a human TNF-receptor:Fc 
fusion protein (Enbrel) which is a TNF inhibitor with human/
mouse cross-reactivity (18). After 8  days in M-CSF-containing 
medium the bone marrow derived undifferentiated macrophages 
expressed IL-6 (Figures 9A,G). Additional exposure to IL-4 for 
48 h induced macrophages from both B6.WT and B6.TNF−/− mice 
to display CD206 (Figures 9B,H). The level of IL-6 was largely 
unchanged in B6.WT macrophages but strongly upregulated in 
B6.TNF−/− macrophages. Interestingly, macrophages pretreated 
with increasing concentrations of Enbrel (5, 10, 25, 50  µg/ml) 
and then exposed to IL-4 not only upregulated the expression 
of CD206 but also increased the level of IL-6 (Figures  9C–F). 
Together, these data showed that IL-6 was associated with 
IL-4-driven alternative macrophage activation. The presence of 
TNF inhibited this process as indicated by a downregulation of 
Arg-1 and CD206. In contrast, blockade of TNF was facilitating 
a CD206 and IL-6 expression, supporting recent data obtained in 
TNF−/− mice (12) and suggesting a balancing effect between TNF 
and IL-6 in alternative macrophage activation.
The regulatory effect of the Balance 
between TnF and il-6 affects gp130/
sTaT3 and il-4/sTaT6 signaling
Using qPCR, we examined the expression of the receptor molecules 
specific for IL-6, IL-6 receptor (IL-6R), and gp130, to determine 
which signaling pathway is active after stimulation with TNF 
and IL-6 in M2 macrophages. There was no significant change 
of IL-6R mRNA while gp130 was increased significantly in the 
IL-6-treated group but its expression was reduced when cells were 
additionally exposed to TNF (Figure 10A). A Western Blot analy-
sis of IL-6R and gp130 showed an upregulation of these molecules 
in the presence of IL-6 and a significant downregulation by TNF 
(Figures 10B–D). Further analysis of the levels of STAT3 and 6 
demonstrated that the protein expression of these transcription 
factors was unchanged per se but that the level of phosphorylation 
decreased in the presence of TNF (Figures 10B,E,F).
MaTerials anD MeThODs
Mouse strains
C57BL/6J mice (B6.WT), BALB/c mice (both Jackson Labo-
ratories, Bar Harbor, ME, USA) and C57BL/6J mice genetically 
deficient for the tnf gene (B6.TNF−/−) (19) were used at 6–12 weeks 
of age. All mice were kept under specific pathogen-free condi-
tions at the animal facilities of the Menzies Institute for Medical 
Research, Hobart, Australia. Infection was performed with 
sex- and age-matched B6.WT and B6.TNF−/− mice. Animal care 
and experiments were approved by the animal ethics committee 
of the University of Tasmania, Hobart, Australia (Animal Ethics 
Number: A13934 and A13935).
culture of L. major and infection
The virulent L. major strain BNI (MHOM/IL/81/FE/BNI) 
was kindly provided by Prof. Christian Bogdan (Institute of 
Microbiology, Hygiene and Immunology, Erlangen, Germany). 
The infectivity of the parasites was maintained by passage 
through the tissue of susceptible BALB/c mice as described 
(20). Prior to infection, the parasites were cultured in  vitro in 
Novy-MacNeal-Nicolle blood agar slants in RPMI 1640 medium 
(Thermo Fisher Scientific, VIC, Australia) containing 10% rabbit 
serum (Applied Biological Products Management, SA, Australia), 
penicillin/streptomycin, nonessential amino acids, and 10  mM 
HEPES (Thermo Fisher Scientific) as described (10, 20). Mice 
were injected with 3 × 106 stationary-phase L. major promasti-
gotes bilaterally into the skin of the hind footpads. The progress 
FigUre 7 | The effect of tumor necrosis factor (TNF) and IL-6 in monocyte differentiation. (a) Bone marrow monocytes were cultured for 4 days with granulocyte 
macrophage colony-stimulating factor and IL-4. IL-6 and/or TNF were added after day 4. At day 7, differentiation was monitored using the expression of CD11b, 
CD11c, and M-CSFR (CD115) using flow cytometry. A representative result is shown. (B) Quantification the results of a CD11b versus M-CSFR (CD115) staining of 
three independent differentiation experiments. The p-values were calculated using one-way ANOVA (*p < 0.05). (c) Immunofluorescence photographs represent 
sections of cells from each culture condition labeled for M-CSFR (red) CD11c (green) and DAPI (blue). (D) qPCR data revealed M-CSFR gene expression in cells 
treated with IL-6 and TNF. The results are representative of three independent experiments. Means ± SD were calibrated to median values of three experiments. The 
p-values were calculated using one-way ANOVA and Tukey’s comparison test (*p < 0.05 and ##p < 0.01).
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FigUre 9 | Blocking tumor necrosis factor skews macrophage 
differentiation. Bone marrow-derived macrophages from B6.WT (a–F) and 
B6.TNF (g,h) mice were cultured with IL-4 and different concentrations of 
etanercept (Enbrel). Immunofluorescence photographs represent cells from 
each culture condition labeled for IL-6 (red), CD206 (green), and DAPI (blue). 
One of three independent experiments is shown.
FigUre 8 | The effect of tumor necrosis factor (TNF) and IL-6 in 
macrophage differentiation. Bone marrow-derived macrophages were 
cultivated in the presence of macrophage colony-stimulating factor and 
harvested after 8 days. Subsequently, macrophages were exposed to LPS 
and interferon-γ or IL-4 for 24 h to generate M1 and M2 macrophages. 
The upregulation of the marker molecules F/80 and CD206 was 
quantified. Unchanged macrophages were considered as M0 phenotype. 
(a) M0, M1, and M2 macrophages were incubated with IL-6 or IL-6/TNF, 
and differentiation was analyzed. All the data are presented as 
means ± SD after normalization to control group values of three 
experiments. The p-values were calculated using one-way ANOVA and 
Tukey’s comparison test (*p < 0.05 when compared to the control group, 
and #p < 0.05 when comparing to the IL-6-treated group). (B) Flow 
cytometry of cells from each culture condition using the macrophage 
markers F4/80 and CD206. (c) Quantification of the expression of 
inducible nitric oxide synthase (iNOS), arginase-1 (Arg-1), and CD206 in 
M2 macrophages treated with IL-6 and TNF using qPCR. Results are 
representative of three independent experiments, and presented as 
mean ± SD normalized with regard to the control group. The p-values 
were calculated using one-way ANOVA and Tukey’s comparison test 
(**p < 0.01 when compared to control group, and #p < 0.05, ##p < 0.01 
when compared to the IL-6-treated group).
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of the infection was monitored by measuring the footpad swelling 
(lesion size) using a metric caliper (10).
Limiting dilution experiments were performed to determine 
the parasite burden in the infected liver. Single cell suspensions 
were prepared in supplemented Schneider’s media (Thermo 
Fisher Scientific) and serial dilutions (threefold) were pipetted 
across a 96-well plate with 12 replicates in an end-point titra-
tion. The plates were incubated for 10–14 days at 27°C before the 
number of Leishmania-positive wells were determined using both 
a light microscope Olympus CKX31 (Olympus, VIC, Australia) 
and a spectra Max/M2 Microplate reader (Molecular Devices, 
Sunnyvale, CA, USA). The parasitic burden was calculated as 
described (10).
cBa assay
Mouse whole blood was collected by cheek bleeding. Mouse 
serum was stored at −80°C for further use. Cytokine titers of IL-6, 
IL-10, MCP-1, IFN-γ, TNF, and IL-12p70 were determined in 
serum using the mouse inflammation CBA kit (BD Biosciences, 
NSW, Australia) following the manufacturer’s instructions. 
Samples were acquired on a BD FACSCanto II using FACSDiva 
6.1 software and analyzed with FCAP Array version 1.0 software 
(BD Biosciences).
liver Mononuclear cell isolation
Mice were sacrificed by CO2 and then perfused slowly via the 
ascending aorta with 30  ml PBS and EDTA (Thermo Fisher 
FigUre 10 | The regulatory effects of tumor necrosis factor (TNF) and IL-6 affect the expression of gp130 and IL-6R and the phosphorylation of signal transducer 
and activator of transcription (STAT) 3 and STAT6. (a) qRT-PCR analysis of different signaling molecules in M2 macrophages treated with IL-4 and TNF. Results were 
normalized to the control group and represent means ± SD of three experiments. Statistical analysis was performing using ANOVA with Tukey’s posttest, and the 
results were considered significant with a *p < 0.05, **p < 0.01 when compared to the control group, and #p < 0.05 and ##p < 0.01 when compared to the 
IL-6-treated group. (B) Western Blot analysis of IL-6R, gp130 and b-actin as loading control. Furthermore, the transcription factors signal transducer and activator of 
transcription (STAT) 3 and STAT6 were analyzed as phosphorylated and non-phosphorylated proteins. One of three experiments is shown. (c,D) Changes of IL-6R 
and gp130 relative to β-actin are shown. (e,F) The ratio of as phosphorylated and non-phosphorylated STAT3 and 6 is depicted. Results were calibrated to the 
control group value and represent means ± SD of three experiments. *p < 0.05, **p < 0.01 when compared to the control group, #p < 0.05 and ##p < 0.01 when 
compared to the IL-6-treated group. One-way ANOVA analysis with Tukey’s postcomparison.
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Scientific). Livers were then removed and stored as required. 
Isolation of liver mononuclear cell was achieved by cutting the 
organ in small pieces and then digesting it in Hank’s Balanced 
Salt solution (Thermo Fisher Scientific) containing collagenase 
II (100  U/ml, Thermo Fisher Scientific) and DNase I (1  U/μl, 
Sigma-Aldrich, NSW, Australia) for 30 min at 37°C shaking at 
200 rpm. The suspension was filtered through a 100 µm strainer 
(Thermo Fisher Scientific) to remove tissue debris. Cells were 
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resuspended in PBS/BSA and mononuclear cell were isolated 
using a Histopaque 1083 gradient (Sigma-Aldrich). The gradient 
was initially centrifuged at 80 g for 3 min followed by centrifuga-
tion at 1,400 g for 15 min at 4°C. The cells at the interface were 
harvested, resuspended in 10 ml PBS and centrifuged at 600 g for 
10 min at 4°C. The pellet was resuspended in PBS and the cell 
number determined in a Neubauer hemocytometer (Australian 
Scientific, NSW, Australia).
generation and Tissue culture of Bone 
Marrow-Derived Macrophages and Dc
BM  cells were flushed from femur and tibia of uninfected 
B6.WT and B6.TNF−/− mice and cultured in RPMI 1640 media 
(Thermo Fisher Scientific) supplemented as described with 
penicillin/streptomycin, nonessential amino acids, and 10  mM 
HEPES (Thermo Fisher Scientific) and either 10% of L929 tissue 
culture supernatant containing macrophage colony stimulating 
factor (M-CSF) for 7  days (21) or 10% tissue culture superna-
tant of GM-CSF-transfected X63-AG8 cells for 10  days (22). 
Recombinant mouse IFN-γ (20  ng/ml; Peprotech, Lonza, VIC, 
Australia) and IL-4 (10 ng/ml; Peprotech) were added into the 
medium for 24 h to differentiate M1 and M2, respectively. For 
the final 24 h, recombinant mouse IL-6 (10 ng/ml, Peprotech), 
TNF (Peprotech) were added. In blocking experiments increas-
ing concentrations of a human TNFR:Fc (Enbrel; Amgen, North 
Ryde, NSW, USA) were added for 4 h before the addition of IL-4.
Flow cytometry and cell sorting
Multicolor flow cytometry was performed following an esta-
blished protocol (23). Cells were stained first for surface marker 
expression with rat antimouse CD45 (Biotinylated; 30-F11; BD 
Biosciences), rat antimouse Ly6C (FITC; clone HK 1.4; BioLegend, 
WA, Australia), rat antimouse F4/80 (APC-Cy7; clone BM8; eBio-
science, VIC, Australia), and rat antimouse CD11b (PerCP-Cy5.5; 
clone M1/70; BD Biosciences). For intracellular flow cytometry the 
cells were fixed with FOXP3 Fix/Perm buffer and permeabilized 
with FOXP3 Perm buffer (BioLegend) according to the manufac-
turer’s protocol. Intracellular proteins were targeted with rat anti-
mouse CD206 (PE; clone C068C2; BioLegend), rat antimouse IL-6 
(PE; clone MP5-20F3; BD Biosciences), rat antimouse IFN-γ (PE; 
clone XMGI-2; BD Biosciences), rabbit anti-L. major [clone V121 
(11)], and mouse antimouse Arg-1 (PE; polyclonal antiserum; 
R&D Systems, Sydney, NSW, Australia). Streptavidin conjugated 
to V500 (BD Biosciences) was used to reveal biotinylated primary 
mAbs. Cells were acquired on a BD FACSCanto II flow cytometer 
using BD FACSDiva version 6.1.3 (BD Biosciences) and analyzed 
with FlowJo software version 10.1(Tree Star Inc., Ashland, OR, 
USA). For flow cytometric cell sorting, two populations defined 
by CD45+F4/80+CD11b+Ly6Clow and CD45+F4/80+CD11b+Ly6Chi 
were sorted using a Beckman Coulter Astrios MoFlo. For liver DC 
marker comparison, CD11c (PE-Cy7; clone HL3; BD Biosciences) 
was used. Bone marrow-derived cells were stained with CD11b 
(FITC; clone M1/70; BD Biosciences), CD11c (PE-Cy7; clone 
HL3; BD Biosciences), F4/80 (APC-Cy7; clone BM8; eBioscience), 
CD206 (PE; clone C068C2; BioLegend), and M-CSFR (APC; clone 
AFS98; Biolegend) as experiments required.
immunohistochemistry
Liver tissue specimen was fixed in formalin and embedded in 
paraffin. Histological sections of 4  µm thickness were stained 
with hematoxylin and eosin using a standard protocol. The 
histopathological changes before and after L. major infection 
were observed using a Leica DM2500 (North Ryde, Australia). 
To assess the degree of inflammation, three representative inflam-
matory foci were imaged at 100× magnification. The number of 
inflammatory foci in each image was quantified and the average 
for each of the three representative areas per animal was then 
calculated.
For immunohistochemical staining, tissue sections were de- 
paraffinized in xylene and rehydrated. The antigens were retri-
eved in 10  mmol/l sodium citrate buffer (pH 9.0) for 10  min 
at 100°C and then cooled to room temperature before being 
stained. Endogenous peroxidase activity was quenched by treat-
ment with 3% H2O2 in methanol for 10 min. The sections were 
blocked in protein block (X0909, Dako, VIC, Australia) for 
30 min at room temperature and then incubated with a primary 
mAb to CD68 (ab31630, Abcam, VIC, Australia) for 1 h at 37°C. 
Immunoreactivity was visualized with diaminobenzidine (Dako) 
using the Envision system (Dako) according to the manufacturer’s 
protocol. The nuclei were lightly counterstained with hematoxylin 
solution. A negative control was prepared using the same stain-
ing procedure but was not incubated with the abovementioned 
primary antibodies. Images were obtained using an Olympus 
BX53 microscope (Olympus), and semiquantitative analysis was 
conducted using Image-Pro Plus software (ImageJ, USA).
Flow cytometrically sorted cells were centrifuged on slides in a 
Cytospin™ 4 Cytocentrifuge (Thermo Fisher Scientific) at 500 g 
for 10 min and underwent microscopical analysis after air-drying 
and staining with Diff-Quik reagent.
immunofluorescence
Liver tissue samples were dissected and rapidly frozen in Tissue-
Tek optimal cutting temperature medium (VWR, QLD, Australia) 
in liquid nitrogen vapor and stored at −80°C. Sections (8 µm) 
were cut using a cryotome (Thermo Fisher Scientific), air-dried, 
and fixed in acetone at −20°C. Prior to staining, sections were 
rehydrated in PBS/1% BSA for 60 min. Sections were incubated 
for 60 min with a biotinylated or purified antibody, washed three 
times with PBS/BSA and labeled for 60  min with a secondary 
reagent. The primary antibodies and the second labeling reagents 
are described in Table  1. Sections were mounted with polyvi-
nyl alcohol mounting media with DABCO (Sigma-Aldrich) 
to prevent fading. Anti-Leishmania antibodies (clone V121, 
MHOM/IL/67/Jericho II) were purified from rabbit serum (a 
generous gift from Emanuela Handman, WEHI, Australia) (11). 
Immunofluorescence images were visualized using UltraView 
Spinning disk confocal microscope with Velocity Software 
(Perkin Elmer, MA, USA). All the images were processed using 
ImageJ version 1.50i (ImageJ, USA).
Quantitative real-Time Pcr
RNA was extracted from sorted liver macrophages and from 
tissue culture by using Tri-Reagent (Sigma-Aldrich) and RNA 
TaBle 2 | Primers used for qPCR characterizing monocytes.
gene Forward primer reverse primer Product size (bp)
Arg-1 ATGGAAGAGAC 
CTTCAGCTAC
GCTGTCTTCCCA 
AGAGTTGGG
224
iNOS GGAATCTTGGA 
GCGAGTTGT
CCTCTTGTCTTT 
GACCCAGTAG
99
CD206 TGCAAAGCTATA 
GGTGGAGAGC
ACGGGAGAAC 
CATCACTCC
164
IL-6 AGTTGCCTTCTT 
GGGACTGA
TCCACGATTTC 
CCAGAGAAC
159
CD115 TCATTCAGAGCC 
AGCTGCCCAT
ACAGGCTCCCA 
AGAGGTTGACT
560
STAT3 CAAGCCTTTCC 
TGACAGAGG
AGACAATGTC 
CTCACTGCCC
221
STAT6 CATCTGAACCG 
ACCAGGAACT
CTCTGTGGGG 
CCTAATTTCCA
135
IL-6R TGGGACCCGAG 
TTACTACTT
TGGATGACGCAT 
TGGTACTG
110
β-Actin AGAGGGAAATCG 
TGCGTGAC
CAATAGTGATGAC 
CTGGCCGT
138
TaBle 1 | Primary and secondary antibodies used in confocal microscopy.
host Target Fluorochrome clone supplier
Primary antibodies Rabbit L. major – V121 M. Mack, Regensburg
Rat CD11b Biotin M1/70 BD Biosciences
Mouse iNOS – 6/iNOS/NOS Type II BD Biosciences
Rat CD206 – MR5D3 BD Biosciences
Rat IL-6 Biotin MP5-32C11 BioLegend
Secondary reagents Rat Streptavidin Alexa Fluor 546 – Thermo Fisher Scientific
Donkey Rat IgG Alexa Fluor 647 – Thermo Fisher Scientific
Goat Rabbit IgG Alexa Fluor 488 – Thermo Fisher Scientific
Goat Mouse IgG Alexa Fluor 647 – Thermo Fisher Scientific
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isolation mini kit (Bioline, Alexandria, Australia) according to the 
manufacturer’s instructions. RNA was stored in RNase-free water 
at −80°C. The QuantiTect Reverse Transcription Kit (Qiagen, 
Melbourne, VIC, Australia) was used to reverse-transcribe up to 
1,000 ng total RNA. cDNA (2 µL) was amplified by Quantitative 
real-time PCR on the Rotor-Gene Q qPCR instrument (Qiagen) 
with 10  µl reactions using the SensiFAST™ SYBR No-Rox Kit 
(Bioline). The appropriate oligonucleotide primers were listed 
in Table 2, and the reaction was performed under the following 
conditions: samples were heated at 95°C for 3 min and amplified 
with 40 cycles of 95°C for 10 s, 60°C for 15 s, and 72°C for 30 s. 
Reactions were performed in duplicate and gene expression levels 
were normalized to β-actin. Relative gene expression between 
samples was calculated using the 2−ΔΔCt calculation method.
immunoblotting
Cells were lysed in RIPA lysis buffer (50 mmol/l Tris-HCl, pH 
7.4, 150  mmol/l NaCl, 10  mmol/l phenylmethylsulfonylfluoride, 
1 mmol/l EDTA, 0.1% SDS, 1% Triton X-100, 1% sodium deoxy-
cholate) for 30–40 min on ice. Protein concentrations were deter-
mined using Pierce™ BCA protein assay kit (Thermo Scientific). 
Proteins were resolved by SDS-PAGE and then transferred to 
polyvinylidene fluoride membranes (Millipore, VIC, Australia). 
Membranes were blocked for 1 h at room temperature in 5% skim 
milk in 0.1% TBS/0.1% Tween20 and then incubated overnight 
with rabbit polyclonal antibodies to IL-6Rα (Sino Biological, 
Beijing, China), gp130 (R&D Systems), phospho-STAT6 (R&D 
Systems) and phospho-STAT3 (Cell Signaling Technology), 
STAT-3 (Cell Signaling Technology, QLD, Australia), and goat 
polyclonal antibodies to STAT6 (R&D systems). β-Actin (Abcam) 
was used as loading control.
Membranes were incubated with appropriate antigoat or 
antirabbit secondary antibodies (Santa Cruz, QLD, Australia) 
for 1 h at room temperature. Membranes were washed, incubated 
with Western Lightning Plus Enhanced Chemiluminescence 
Solution (PerkinElmer, Woodbridge, ON, Canada) for 1  min 
and exposed to Amersham Imager 600 (GE Healthcare Life 
Sciences, NSW, Australia) for 5  s to 10  min. For the analysis 
of the ratio of phosphorylated/non-phosphorylated transcrip-
tion factors blots were stripped using mild conditions (Thermo 
Fisher Scientific) and reprobed with the appropriate antibodies. 
The density of the specific bands was quantified using Image J 
software (ImageJ, USA).
statistical analysis
Statistical evaluation of liver weight, limiting dilution, RT-PCR, 
and immunohistochemical analysis results were presented as 
mean ± SD, as appropriate. Results were analyzed using GraphPad 
prism 5 software (Graphpad Software, San Diego, CA, USA) by 
Mann–Whitney tests for samples with unknown and potentially 
disparate variances, or by one-way ANOVA followed by post hoc 
analysis with Tukey’s test with p <  0.05 accepted as a level of 
statistical significance.
DiscUssiOn
Tumor necrosis factor is a pleiotropic cytokine originally named 
after its proposed tumoricidal effects that has since been identi-
fied as a central effector cytokine with a broad range of biological 
activities such as induction of cell death, modification of cell 
migration, and regulation of DCs differentiation in  vitro (24). 
Interestingly, its presence has been shown to be irreplaceable for 
effective immune responses to the bacterial or parasitic intracel-
lular pathogens such as Mycobacterium tuberculosis, Listeria 
monocytogenes, or L. major but the underlying mechanisms that 
lead to this susceptibility are still not clear (10, 25–27).
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After deletion of the tnf gene, normally resistant B6.WT mice 
are unable to control a cutaneous infection with L. major BNI 
(10). They develop a progressive infection that ultimately spreads 
to visceral organs including the liver. In our detailed analysis of 
this organ during L. major infection, we found that after day 21 
after infection the size in B6.TNF−/− mice was enlarged signifi-
cantly and increasing numbers of viable L. major parasites could 
be detected while B6.WT controls essentially remained parasite 
free. The progressive infection that was caused by the absence 
of TNF was accompanied by a strong increase in the proportion 
of Mo-Ms that showed clear signs of alternative activation. The 
marked expression of IL-6 prompted us to analyze the interac-
tion of IL-6 and TNF during macrophage differentiation and the 
signaling pathways via IL-6Ra, gp130, and STAT3 and 6 in vitro. 
Our results point to a role of IL-6 facilitating macrophage dif-
ferentiation downstream of TNF.
Macrophages, while acting as a major reservoir for L. major 
parasites (28), are also potent effector cells that kill parasites 
in  vivo with a strong production of NO (29, 30). In the skin 
and draining local lymph nodes, the tissues predominantly 
analyzed in L. major infection, resident macrophages are initially 
relevant for the immune response but are quickly outnumbered 
by inflammatory monocyte derived DCs (31–33). In the liver, 
which constitutes a major target organ of a visceralized L. major 
infection in immune-incompetent mice, the inflammatory 
infiltration of monocytic cells has not yet been addressed in 
detail. In our study, we defined tissue resident KC, recruited 
inflammatory monocytes (Mo) and the cell types Mo differentiate 
into, Mo-DCs and Mo-M according to their expression of the 
marker molecules CD45, F4/80, CD11b, and Ly6C (13–15) and 
analyzed the dynamic of these cell populations in response to 
L. major infection in the absence of TNF. Fate-mapping has 
demonstrated that liver-resident F4/80+ KC are derived from 
embryonic cells and self-maintain independently from hemat-
opoietic input under non-inflammatory steady state conditions 
(34). These cells have been shown to have an anti-inflammatory 
function that is abrogated by inflammation (35). Only hours after 
inoculation with L. monocytogenes, KC become infected and 
rapidly undergo necroptosis, thereby triggering the recruitment 
of monocytes (13). Unsurprisingly, in the slower moving L. major 
infection we did not see a significant decline of the numbers of 
KC nor did we detect a significant genotype-dependent changes 
between B6.WT and B6.TNF−/− during the course of infection 
(with the exception of day 21 after infection). Interestingly, while 
the number of liver Mo increased in correlation with the lesion 
size but independent of the mouse genotype, the population of 
Mo-M saw a significant increase in TNF-deficient mice but was 
hardly detectable in B6.WT mice. Since Mo-M in the liver differ-
entiate out of the population of Mo in response to inflammatory 
signals (13) this observation could point to an absence of these 
signals in B6.WT mice due to an infection that is contained in 
skin and draining LN or potentially, to a contributing role of TNF 
in the differentiation (12).
Monocytes are present in form of steady-state precursors in 
the peripheral circulation and are recruited to organs such as 
the liver during inflammation (34). Here they differentiate to 
Mo-M and Mo-DCs in response to inflammatory cues. In the 
experiments presented here, the population of Mo increased after 
day 35 p.i. in line with the increased footpad swelling in both 
groups of mice. Numbers of Mo began to decrease at day 42 p.i. 
in B6.WT indicating that during the resolution phase of infection 
the recruitment of Mo ceased. However, in B6.TNF−/− mice Mo 
continued to be recruited and to differentiate into Mo-M resulting 
in a strong presence of this cell type in the late phase of infection. 
Like TNF-deficient mice the highly susceptible BALB/c mice 
fail to control leishmaniaisis. However, Mo-M are not found in 
L major infected BALB/c mice, which supports the notion that an 
accumulation of Mo-M is due specifically to the absence TNF. In 
previous experiments, a similar Mo-M population was observed 
in the skin and the draining lymph node of B6.TNF−/− mice 
during L. major BNI infection. It exhibited a phenotype that was 
CD11b+Ly-6ClowCCR2lowiNOSlow and harbored a large number of 
parasites (11). In further detailed mechanistic analyzes it could be 
demonstrated that these cells coexpressed iNOS with high levels 
of CD206 and Arg-1, which indicated an M2-like phenotype 
(12). This finding was seemingly contradicting a long line of 
publications that showed that TNF was supporting the expres-
sion of iNOS. The role of TNF in the induction of iNOS and the 
effector molecule NO during the innate immune response to 
L. major was investigated initially in in vitro models (36). It could 
be shown that it activated macrophages and synergized with 
IFN-γ to induce effector functions (8, 37). However, in more 
complex in vivo infection models, the well-defined role of TNF in 
the iNOS-inducing cytokine network determined in vitro became 
controversial (38) while the central effector role of NO remained 
undisputed (29, 30). A L. major infection of a TNFR1-negative 
mouse strain showed that in absence of this proinflammatory 
signaling pathway these mice developed persistent lesions but 
controlled the pathogen (38). Further investigations, using 
TNFR2- and TNFR1/2-deficient mice clearly demonstrated that 
the TNFR2 signaling pathway lacked a clear inflammatory func-
tion while the outcome of the infection of mice deficient for both 
TNFR1 and TNFR2 was similar to the TNFR1-negative strain 
(39). Unexpectedly, it became clear that the expression of iNOS 
was sustained in these mice (39). Finally, infection experiments 
using genetically pure TNF-negative C57BL/6 mice resulted in a 
progressive and ultimately fatal, infection (10) despite a strong 
Th1 response which was characterized by a hyper-expression 
of IFN-γ and the presence of iNOS (9, 11). The differences in 
the published clinical outcomes of these infection experiments 
were probably due to variations of the genetic background of the 
parasite strains (40) in combination with a contaminating pres-
ence of congenic regions (41) in the genomes of the TNFR1- and 
2-deficient mice (39).
Recently, the apparent contradiction of the presence of iNOS 
in TNF-deficient mice and their concurrent susceptibility to 
L. major BNI infection could be explained with the observation 
that TNF caused a direct suppression of Arg-1 expression and 
of other molecules associated with an alternative activation of 
myeloid cells. In TNF-negative mice the number of Arg1+ cells 
was increased in skin and draining LN and in the absence of TNF 
a coexpression of Arg-1 and iNOS could be detected. Since both 
enzymes share l-arginine as substrate a coexpression in mac-
rophages caused competition for the substrate. Consequently, loss 
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of TNF significantly reduced the production of NO, resulting in 
fatal leishmaniasis (12). Interestingly, in this model the CD11b+ 
Arg1+ cells isolated from skin and draining LN of L. major BNI-
infected B6.WT and B6.TNF−/− mice were predominately coex-
pressing CD11c+ (12) and had therefore a phenotype that had 
been described earlier in the leishmanial model (42). This aspect 
was not addressed in the present study but it should be noted that 
the concept of inflammatory versus alternative activation can also 
be observed in DC (43). Taken together, our conclusive detection 
of M2 macrophages in the liver has strengthened the concept that 
the M2-suppressing role of TNF is not organ- or tissue-specific 
and, together with the observation of M2-like cells in the spleen 
of L. monocytogenes infected TNF-deficient mice, supports the 
notion of a fundamental, yet so far undescribed biological activity 
of this cytokine (12, 44, 45).
In the present study, we confirmed that IFN-γ was detectable at a 
higher level in B6.TNF−/− mice than in B6.WT mice (9). Similarly, 
MCP-1 (46), a pivotal cytokine implicated in recruitment and 
activation of monocytes (47) was overexpressed in the serum of 
TNF-deficient mice after L. major BNI infection. However, most 
interestingly, we could show that the major proinflammatory 
cytokine IL-6 was significantly overexpressed. Historically, after 
it had been demonstrated that these cytokines were involved in 
the acute phase reaction (48) this pleiotropic cytokine has been 
grouped with IL-1 and TNF as a classical proinflammatory media-
tor that appears early in the immune response (49). The interplay 
of TNF and IL-6 has been addressed in in vitro experiments using 
DC and macrophages. An activation of TNF-negative bone mar-
row derived DC resulted in the secretion of a decreased amount 
of IL-10 but IL-6 production remained unchanged (50). An 
infection with L. major or L. donovani with subsequent activation 
with LPS resulted in a strong IL-6 expression (51). Finally, IL-6 
can downregulate the expression of proinflammatory cytokines 
including TNF (52) and it has been described to skew the dif-
ferentiation of monocytes to macrophages (53). This action can 
be reversed by the additional presence of TNF (16) and this 
activity is caused by opposite effects of these cytokines on M-CSF 
receptor expression and internalization. One major activities of 
IL-6 could potentially be important in vivo during the immune 
response to L. major BNI. The presence of IL-6 has been reported 
to block the differentiation of regulatory T cells (Tregs) and to 
support the generation of IL-17+ Th cells (Th17) (54). However, 
an infection of mice which were genetically deficient for IL-6 with 
L. major demonstrated an effective and protective antileishmanial 
response (55) despite originally having been described to have an 
impaired antibacterial, antiviral, and acute phase response (56); a 
more detailed analysis of the adaptive and the innate branches of 
the immune system could not detect major deficiencies in these 
mice (57).
In the classical IL-6 signaling pathway, IL-6 signal transduction 
requires the formation of a trimer consisting of ligand, the IL-6 
receptor (IL-6R) α-chain and the signal transducing membrane 
glycoprotein gp130. IL-6 binds to membrane-bound IL-6R (mIL-
6Rα) which recruits its signaling component gp130. This combi-
nation contributes to the plethora of pro- and anti-inflammatory 
functions (58). Unlike the ubiquitously distributed gp130, mIL-
6Rα is expressed exclusively on the surface of hepatocytes and 
some myeloid and lymphoid cell populations such as monocytes 
and T  cells (59). However, most proinflammatory functions of 
IL-6 are mediated through a second IL-6-dependent signaling 
pathway via the soluble IL-6R in the IL-6 trans-signaling pathway 
which can trigger IL-6-mediated response in cells negative for 
mIL-6R (58).
In our study, stimulation with IL-6 increased the expression of 
mIL-6R and gp130 but the additional presence of TNF caused a 
rapid downregulation of these receptor molecules and a signifi-
cant reduction of STAT3 and 6 phosphorylation. In the context a 
L. major infection of TNF-competent animals, the role of IL-6 in 
the determination of the outcome of macrophage differentiation 
seems to be negligible (57). This changes however, in the absence 
of TNF. Now a strong expression of IL-6 contributes signifi-
cantly to the dysregulation that leads to a fatal presence of M2 
macrophages in skin (12), lymphoid organs and visceral organs 
such as the liver. Potentially our finding could have ramifications 
for the meanwhile ubiquitous anti-TNF and IL-6 therapy in 
human chronic inflammatory disorders. Therefore, the complex 
regulatory interactions of IL-4, IL-6, and TNF in macrophage 
differentiation need to be investigated at the molecular level in 
more detail (12, 16, 53).
Taken together, we show that in the absence of TNF an infec-
tion with L. major BNI quickly spreads to the liver. The infection 
causes a strong infiltration of monocytes and leads to the pres-
ence of an accumulating number of Mo-Ms which display an M2 
phenotype, express IL-6 and harbor parasites which contributes 
to the fatal outcome of leishmaniasis in these mice. Furthermore, 
we show that in the absence of the M1 determining cytokine 
TNF, anti-inflammatory function of IL-6 can dominate the dif-
ferentiation of monocytes and provide a first insight that this 
cytokine can contribute to the skewing of monocytes to a M2 
phenotype.
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FigUre s1 | Macrophages derive from recruited monocytes. Flow cytometric 
gating strategy and analysis of the three distinct subsets of CD45+ F4/80+ liver 
macrophages after L. major BNI infection.
FigUre s2 | Analysis by immunofluorescence and flow cytometry in  
L. major-infected BALB/c mice. (a) Immunofluorescence staining of CD11b 
(gray), iNOS (green), L. major (red), and DAPI (blue) in liver tissue of BALB/c mice 
postinfection. Results represent one of three biological repeats. (B) Flow 
cytometric analysis revealed the changes of three different CD45+F4/80+ liver 
macrophage populations based on identical gates as in Figure 3 over the course 
of L. major BNI infection.
FigUre s3 | The expression of CD11c on monocytic cells from B6.WT and B6.
TNF−/− mice. (a) Flow cytometric analysis of liver Ly6C+CD11b+ cells obtained 
from L. major BNI-infected B6.WT and B6.TNF−/− mice. The populations of 
Ly6C+CD11b+ cells were gated and the CD11c expression of these cells is 
shown in a representative example. (B) Quantification by flow cytometry of the 
expression of CD11c on the Ly6C+CD11b+ cells upon L. major BNI infection. The 
data represent the median of mean intensity of fluorescence (MIF) of CD11c 
expression by Ly6C+CD11b+ cells upon L. major BNI infection. Results represent 
means ± SD, n = 15. *p < 0.05 comparing to B6.WT group, two-tailed Mann–
Whitney U-test.
FigUre s4 | The morphology of Mo and Mo-M from B6.WT and B6.
TNF−/− mice. (a) Representative Romanowsky (Diff-Quik) stain of liver sections 
are shown (n = 3 per group). After day 42 p.i., L. major BNI parasites were found 
inside and outside of the cells (arrowheads) in the liver of B6.WT and B6.
TNF−/− mice (magnification 400×).
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